Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2003
08/28/2003CA2477074A1 5-heteroaryl substituted indoles
08/28/2003CA2477012A1 Anti-a.beta. antibodies and their use
08/28/2003CA2476854A1 Surrogate antibodies and methods of preparation and use thereof
08/28/2003CA2476822A1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/28/2003CA2476764A1 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003CA2476711A1 Process for preparation of an inhalation powder containing a salt of the cgrp antagonist bibn4096
08/28/2003CA2476681A1 Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease
08/28/2003CA2476665A1 Tricyclic pyrazole derivatives for the treatment of inflammation
08/28/2003CA2476624A1 Azabicyclic compounds for the treatment of disease
08/28/2003CA2476438A1 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
08/28/2003CA2476434A1 Method of treating trx mediated diseases
08/28/2003CA2476422A1 Topiramate salts and compositions comprising and methods of making and using the same
08/28/2003CA2476417A1 Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders
08/28/2003CA2476411A1 Thiazolyl urea compounds for the treatment of cancer
08/28/2003CA2476406A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
08/28/2003CA2476376A1 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
08/28/2003CA2476115A1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists
08/28/2003CA2476112A1 Rna interference mediated inhibition of interleukin gene expression using short interfering nucleic acid (sina)
08/28/2003CA2475374A1 Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence
08/28/2003CA2475357A1 Dose dispensing system and apparatus
08/28/2003CA2474848A1 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/28/2003CA2473100A1 Pyranones useful as atm inhibitors
08/28/2003CA2473089A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/28/2003CA2463595A1 Rna interference mediated inhibition of bcl2 gene expression using short interfering nucleic acid (sina)
08/28/2003CA2459532A1 Rna interference by modified short interfering nucleic acid
08/28/2003CA2455506A1 Rna interference mediated treatment of alzheimer's disease using short interfering nucleic acid (sina)
08/27/2003EP1338607A2 Antigenic iron repressible proteins from n. meningitidis related to the heolysin family of toxins
08/27/2003EP1338605A1 N-alkylglycine trimeres capable of blocking the response to chemical substances, heat stimuli or mediators of neuronal receptor inflammation and compositions containing said trimeres
08/27/2003EP1338604A1 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing said trimeres
08/27/2003EP1338600A1 Fused 1,2,4-Thiadiazine derivatives, their preparation and use
08/27/2003EP1338274A1 Process for preparing a particulate composition
08/27/2003EP1337859A1 Selective anxiolytic therapeutic agents
08/27/2003EP1337855A2 Discordant helix stabilization for prevention of amyloid formation
08/27/2003EP1337655A2 Retroviral vectors containing internal ribosomal entry sites
08/27/2003EP1337560A2 Truncated cd200
08/27/2003EP1337558A2 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
08/27/2003EP1337544A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
08/27/2003EP1337535A2 Benzodiazepine derivatives as gaba a receptor modulators
08/27/2003EP1337532A2 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit
08/27/2003EP1337528A2 Benzothiophene derivative compounds, process of preparation and use thereof
08/27/2003EP1337527A1 Indolylmaleimide derivatives as protein kinase c inhibitors
08/27/2003EP1337523A2 2,4-substituted pyridine derivatives
08/27/2003EP1337518A1 Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
08/27/2003EP1337517A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
08/27/2003EP1337512A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
08/27/2003EP1337272A2 Combination of gaba agonists and aldose reductase inhibitors
08/27/2003EP1337271A2 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
08/27/2003EP1337269A2 Association of calpain inhibitors and reactive oxygen species trapping agents
08/27/2003EP1337265A1 Methods of treatment comprising administration of substance p
08/27/2003EP1337259A2 Methylenetetrahydrofolate reductase inhibitors and use thereof
08/27/2003EP1337257A1 Use of neuropeptide-y antagonists in treatment of alcoholism
08/27/2003EP1337253A1 Novel compounds
08/27/2003EP1337247A1 Gaba enhancers in the treatment of diseases relating to reduced neurosteroid activity
08/27/2003EP1337246A2 Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
08/27/2003EP1337244A1 Controlled release hydrocodone formulations
08/27/2003EP1337243A2 Delayed-release pharmaceutical formulations containing proinsulin c-peptide
08/27/2003EP1337218A2 Substituted felbamate derived compounds
08/27/2003EP1251842B1 Use of modafinil for the manufacture of a medicament for correcting vigilance disorders related to myopathies
08/27/2003EP1189617B1 Pharmaceutical combination with analgesic action containing paracetamol and buspirone
08/27/2003EP1161228B1 Composition comprising isoquercetin and ascorbic acid in a sustained release form
08/27/2003EP1140938B1 High affinity inhibitors for target validation and uses thereof
08/27/2003EP1140889B1 Compounds and methods for modulation of estrogen receptors
08/27/2003EP1124577B1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS
08/27/2003EP1115384B1 Fentanyl composition for the treatment of acute pain
08/27/2003EP1109806B1 Complexes of paroxetine, with cyclodextrins or cyclodextrin derivates
08/27/2003EP1095039B1 New pharmaceutically active compounds
08/27/2003EP1036794B1 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
08/27/2003EP1007520B1 2-aminopyridines containing fused ring substituents as nos inhibitors
08/27/2003EP0981515B1 Piperidine derivatives as neurotransmitter re-uptake inhibitors
08/27/2003EP0906089B1 Buccal delivery system
08/27/2003EP0901469B1 Arylalkylpiperazine compounds as antioxidants
08/27/2003EP0891363B1 Heterocyclic compounds and their preparation and use
08/27/2003EP0739342B1 Pyridine modulators of acetylcholine receptors
08/27/2003CN1439017A Novel compounds
08/27/2003CN1439010A Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
08/27/2003CN1439009A Imidazo pyrimidine derivatives and triazolopyrimidine derivatives
08/27/2003CN1439004A Indole derivatives useful for treatment of CNS-disorders
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/27/2003CN1439002A Muscarinic agonists
08/27/2003CN1439001A Tetrahydropyridino or piperidino hetlrocyclic derivatives
08/27/2003CN1438997A Inhibitors of 11-beta-hydroxy steroid dehydrogenase typeÔàá"
08/27/2003CN1438996A Bicyclic cyclohexylamines and their use NMDA receptor antogonists
08/27/2003CN1438897A Remedial agent for anxiety neurosis or depression and piperazine derivative
08/27/2003CN1438894A Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking LFA-1 medicated adhesion
08/27/2003CN1438893A Therapeutical use of sophora flavescens or sophora subprostrated extracts
08/27/2003CN1438891A Nucleoside analogs with carboxamidine wodified monocyclic base
08/27/2003CN1438890A 腺苷受体调制剂 Adenosine receptor modulators
08/27/2003CN1438885A Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
08/27/2003CN1438884A Therapeutic combinations of fatty acids
08/27/2003CN1438883A Beta Secretase inhibitors
08/27/2003CN1438878A Topical pharmaceutical formulations and methods of treatment
08/27/2003CN1438861A Minimizing adverse experience associated with oxybutynin therapy
08/27/2003CN1438005A Medicine for vascular denmentia disease and preparation method
08/27/2003CN1437988A Liver-protecting and sobering capsule and its production method
08/27/2003CN1437972A Method for extracting effective matter in North Fructus schisandrae
08/27/2003CN1437954A Nutrient tablet for sobering and protecting liver
08/27/2003CN1119346C Benzothiadiaxoles and derivatives
08/27/2003CN1119340C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
08/27/2003CN1119336C Novel compounds with analgesic effect
08/27/2003CN1119328C Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
1 ... 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 ... 1833